However, recent gene expression profiling shows that these two models are highly similar [45], suggesting that the difference in the route of tumor initiation in the ApcMin/+ and AOM models likely does not contribute to molecular differences resulting in ERBB3 sensitivity. The gene discussed is ERBB3; the disease is neoplasm.